Probe Scientific (United Kingdom) a commercial-stage medical device company focused on a platform for the automated monitoring of substances (such as electrolytes, metabolites, amino acids and hormones) in circulating blood without withdrawing blood, closed a $1.6M Series A financing. Participants include Catapult Venture Managers.